반응 #43267

ord-b0f28dd913ac49b39384885491f565e4

반응 방정식

CCOC(=O)C(C#N)=NOC(N(C)C)=[N+](C)C.F[B-](F)(F)F
TOTU
CN1c2ccccc2S(=O)(=O)c2ccc(C(CC3CCOCC3)C(=O)O)cc21
2-(10-methyl-5,5-dioxo-5,10-dihydrophenothiazin-2-yl)-3-(tetrahydropyran-4-yl)propionic acid
Nc1nccs1
2-aminothiazole
CCN(C(C)C)C(C)C
N,N-diisopropylethylamine
CN1c2ccccc2S(=O)(=O)c2ccc(C(CC3CCOCC3)C(=O)Nc3nccs3)cc21
2-(10-Methyl-5,5-dioxo-5,10-dihydrophenothiazin-2-yl)-3-(tetrahydropyran-4-yl)-N-thiazol-2-ylpropionamide

반응 조건

상세 조건
See reaction.notes.procedure_details.

후처리

  1. 1
    세척washed five times with in each case 30 ml of saturated sodium bicarbonate solution
  2. 2
    건조The organic phase is dried over MgSO4
  3. 3
    기타the solvent is then removed under reduced pressure
  4. 4
    기타The residue is purified by RP-HPLC

실험 절차

200 mg of 2-(10-methyl-5,5-dioxo-5,10-dihydrophenothiazin-2-yl)-3-(tetrahydropyran-4-yl)propionic acid, 74.8 mg of commercially available 2-aminothiazole and 220 μl of N,N-diisopropylethylamine are dissolved in 10 ml of dimethylformamide. 212 mg of TOTU are added, and the mixture is stirred at room temperature overnight. The reaction mixture is then diluted by addition of 50 ml of ethyl acetate and washed five times with in each case 30 ml of saturated sodium bicarbonate solution. The organic phase is dried over MgSO4, and the solvent is then removed under reduced pressure. The residue is purified by RP-HPLC. This gives 141 mg of 2-(10-methyl-5,5-dioxo-5,10-dihydrophenothiazin-2-yl)-3-(tetrahydropyran-4-yl)-N-thiazol-2-ylpropionamide as a colorless lyophilisate.

출처

DOI: 10.6084/m9.figshare.5104873.v1특허: US07732440B2uspto-grants-2010_06